Phosphorylation of thymidine and AZT in heart mitochondria: Elucidation of a novel mechanism of AZT cardiotoxicity

Edward E. McKee, Alice T. Bentley, Matthew Hatch, Joel Gingerich, Delia Susan-Resiga

Research output: Contribution to journalArticle

50 Citations (Scopus)

Abstract

Antiretroviral nucleoside analogs used in highly active antiretroviral therapy (HAART) are associated with cardiovascular and other tissue toxicity associated with mitochondrial DNA depletion, suggesting a block in mitochondrial (mt)-DNA replication. Because the triphosphate forms of these analogs variably inhibit mt-DNA polymerase, this enzyme has been promoted as the major target of toxicity associated with HAART. We have used isolated mitochondria from rat heart to study the mitochondrial transport and phosphorylation of thymidine and AZT (azidothymidine, or zidovudine), a component used in HAART. We demonstrate that isolated mitochondria readily transport thymidine and phosphorylate it to thymidine 5′-triphosphate (TTP) within the matrix. Under identical conditions, AZT is phosphorylated only to AZT-5′-monophosphate (AZT-MP). The kinetics of thymidine and AZT suggest negative cooperativity of substrate interaction with the enzyme, consistent with work by others on mitochondrial thymidine kinase 2. Results show that TMP and AZT-MP are not transported across the inner membrane, suggesting that AZT-MP may accumulate with time in the matrix. Given the lack of AZT-5′-triphosphate (AZT-TP), it seems unlikely that the toxicity of AZT in the heart is mediated by AZT-TP inhibition of DNA polymerase γ. Rather, our work shows that AZT is a potent inhibitor of thymidine phosphorylation in heart mitochondria, having an inhibitory concentration (IC)50 of 7.0 0.9 μM. Thus, the toxicity of AZT in some tissues may be mediated by disrupting the substrate supply of TTP for mt-DNA replication.

Original languageEnglish (US)
Pages (from-to)155-167
Number of pages13
JournalCardiovascular Toxicology
Volume4
Issue number2
DOIs
StatePublished - Oct 14 2004

Fingerprint

Heart Mitochondria
Phosphorylation
Mitochondria
Mitochondrial DNA
Thymidine
Toxicity
Highly Active Antiretroviral Therapy
Zidovudine
DNA-Directed DNA Polymerase
DNA Replication
Thymidine Monophosphate
Tissue
Substrates
Enzymes
Nucleosides
Inhibitory Concentration 50
Rats
Membranes
Kinetics
Cardiotoxicity

Keywords

  • AZT cardiotoxicity
  • Heart mitochondria
  • Mitochondrial DNA depletion
  • Thymidine kinase
  • TMP kinase

ASJC Scopus subject areas

  • Toxicology
  • Cardiology and Cardiovascular Medicine

Cite this

Phosphorylation of thymidine and AZT in heart mitochondria : Elucidation of a novel mechanism of AZT cardiotoxicity. / McKee, Edward E.; Bentley, Alice T.; Hatch, Matthew; Gingerich, Joel; Susan-Resiga, Delia.

In: Cardiovascular Toxicology, Vol. 4, No. 2, 14.10.2004, p. 155-167.

Research output: Contribution to journalArticle

McKee, Edward E. ; Bentley, Alice T. ; Hatch, Matthew ; Gingerich, Joel ; Susan-Resiga, Delia. / Phosphorylation of thymidine and AZT in heart mitochondria : Elucidation of a novel mechanism of AZT cardiotoxicity. In: Cardiovascular Toxicology. 2004 ; Vol. 4, No. 2. pp. 155-167.
@article{14606eeab48e4af180810122cc0cf59e,
title = "Phosphorylation of thymidine and AZT in heart mitochondria: Elucidation of a novel mechanism of AZT cardiotoxicity",
abstract = "Antiretroviral nucleoside analogs used in highly active antiretroviral therapy (HAART) are associated with cardiovascular and other tissue toxicity associated with mitochondrial DNA depletion, suggesting a block in mitochondrial (mt)-DNA replication. Because the triphosphate forms of these analogs variably inhibit mt-DNA polymerase, this enzyme has been promoted as the major target of toxicity associated with HAART. We have used isolated mitochondria from rat heart to study the mitochondrial transport and phosphorylation of thymidine and AZT (azidothymidine, or zidovudine), a component used in HAART. We demonstrate that isolated mitochondria readily transport thymidine and phosphorylate it to thymidine 5′-triphosphate (TTP) within the matrix. Under identical conditions, AZT is phosphorylated only to AZT-5′-monophosphate (AZT-MP). The kinetics of thymidine and AZT suggest negative cooperativity of substrate interaction with the enzyme, consistent with work by others on mitochondrial thymidine kinase 2. Results show that TMP and AZT-MP are not transported across the inner membrane, suggesting that AZT-MP may accumulate with time in the matrix. Given the lack of AZT-5′-triphosphate (AZT-TP), it seems unlikely that the toxicity of AZT in the heart is mediated by AZT-TP inhibition of DNA polymerase γ. Rather, our work shows that AZT is a potent inhibitor of thymidine phosphorylation in heart mitochondria, having an inhibitory concentration (IC)50 of 7.0 0.9 μM. Thus, the toxicity of AZT in some tissues may be mediated by disrupting the substrate supply of TTP for mt-DNA replication.",
keywords = "AZT cardiotoxicity, Heart mitochondria, Mitochondrial DNA depletion, Thymidine kinase, TMP kinase",
author = "McKee, {Edward E.} and Bentley, {Alice T.} and Matthew Hatch and Joel Gingerich and Delia Susan-Resiga",
year = "2004",
month = "10",
day = "14",
doi = "10.1385/CT:4:2:155",
language = "English (US)",
volume = "4",
pages = "155--167",
journal = "Cardiovascular Toxicology",
issn = "1530-7905",
publisher = "Humana Press",
number = "2",

}

TY - JOUR

T1 - Phosphorylation of thymidine and AZT in heart mitochondria

T2 - Elucidation of a novel mechanism of AZT cardiotoxicity

AU - McKee, Edward E.

AU - Bentley, Alice T.

AU - Hatch, Matthew

AU - Gingerich, Joel

AU - Susan-Resiga, Delia

PY - 2004/10/14

Y1 - 2004/10/14

N2 - Antiretroviral nucleoside analogs used in highly active antiretroviral therapy (HAART) are associated with cardiovascular and other tissue toxicity associated with mitochondrial DNA depletion, suggesting a block in mitochondrial (mt)-DNA replication. Because the triphosphate forms of these analogs variably inhibit mt-DNA polymerase, this enzyme has been promoted as the major target of toxicity associated with HAART. We have used isolated mitochondria from rat heart to study the mitochondrial transport and phosphorylation of thymidine and AZT (azidothymidine, or zidovudine), a component used in HAART. We demonstrate that isolated mitochondria readily transport thymidine and phosphorylate it to thymidine 5′-triphosphate (TTP) within the matrix. Under identical conditions, AZT is phosphorylated only to AZT-5′-monophosphate (AZT-MP). The kinetics of thymidine and AZT suggest negative cooperativity of substrate interaction with the enzyme, consistent with work by others on mitochondrial thymidine kinase 2. Results show that TMP and AZT-MP are not transported across the inner membrane, suggesting that AZT-MP may accumulate with time in the matrix. Given the lack of AZT-5′-triphosphate (AZT-TP), it seems unlikely that the toxicity of AZT in the heart is mediated by AZT-TP inhibition of DNA polymerase γ. Rather, our work shows that AZT is a potent inhibitor of thymidine phosphorylation in heart mitochondria, having an inhibitory concentration (IC)50 of 7.0 0.9 μM. Thus, the toxicity of AZT in some tissues may be mediated by disrupting the substrate supply of TTP for mt-DNA replication.

AB - Antiretroviral nucleoside analogs used in highly active antiretroviral therapy (HAART) are associated with cardiovascular and other tissue toxicity associated with mitochondrial DNA depletion, suggesting a block in mitochondrial (mt)-DNA replication. Because the triphosphate forms of these analogs variably inhibit mt-DNA polymerase, this enzyme has been promoted as the major target of toxicity associated with HAART. We have used isolated mitochondria from rat heart to study the mitochondrial transport and phosphorylation of thymidine and AZT (azidothymidine, or zidovudine), a component used in HAART. We demonstrate that isolated mitochondria readily transport thymidine and phosphorylate it to thymidine 5′-triphosphate (TTP) within the matrix. Under identical conditions, AZT is phosphorylated only to AZT-5′-monophosphate (AZT-MP). The kinetics of thymidine and AZT suggest negative cooperativity of substrate interaction with the enzyme, consistent with work by others on mitochondrial thymidine kinase 2. Results show that TMP and AZT-MP are not transported across the inner membrane, suggesting that AZT-MP may accumulate with time in the matrix. Given the lack of AZT-5′-triphosphate (AZT-TP), it seems unlikely that the toxicity of AZT in the heart is mediated by AZT-TP inhibition of DNA polymerase γ. Rather, our work shows that AZT is a potent inhibitor of thymidine phosphorylation in heart mitochondria, having an inhibitory concentration (IC)50 of 7.0 0.9 μM. Thus, the toxicity of AZT in some tissues may be mediated by disrupting the substrate supply of TTP for mt-DNA replication.

KW - AZT cardiotoxicity

KW - Heart mitochondria

KW - Mitochondrial DNA depletion

KW - Thymidine kinase

KW - TMP kinase

UR - http://www.scopus.com/inward/record.url?scp=4744372267&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=4744372267&partnerID=8YFLogxK

U2 - 10.1385/CT:4:2:155

DO - 10.1385/CT:4:2:155

M3 - Article

C2 - 15371631

AN - SCOPUS:4744372267

VL - 4

SP - 155

EP - 167

JO - Cardiovascular Toxicology

JF - Cardiovascular Toxicology

SN - 1530-7905

IS - 2

ER -